Is senescence-associated β-galactosidase a marker of neuronal senescence?

Oncotarget. 2016 Dec 6;7(49):81099-81109. doi: 10.18632/oncotarget.12752.

Abstract

One of the features of cellular senescence is the activity of senescence-associated- β-galactosidase (SA-β-gal). The main purpose of this study was to evaluate this marker of senescence in aging neurons. We found that cortical neurons exhibited noticeable SA-β-gal activity quite early in culture. Many SA-β-gal-positive neurons were negative for another canonical marker of senescence, namely, double-strand DNA breaks (DSBs). Moreover, DDR signalling triggered by low doses of doxorubicin did not accelerate the appearance of neuronal SA-β-gal. In vivo, we observed pronounced induction of SA-β-gal activity in the hippocampus of 24-month-old mice, which is consistent with previous findings and supports the view that at this advanced age neurons developed a senescence-like phenotype. Surprisingly however, relatively high SA-β-gal activity, probably unrelated to the senescence process, was also observed in much younger, 3-month-old mice. In conclusion, we propose that SA-β-gal activity in neurons cannot be attributed uniquely to cell senescence either in vitro or in vivo. Additionally, we showed induction of REST protein in aging neurons in long-term culture and we propose that REST could be a marker of neuronal senescence in vitro.

Keywords: DNA damage response; SA-β-galactosidase; aging; neurons; senescence.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Aging / genetics
  • Aging / metabolism*
  • Aging / pathology
  • Animals
  • Biomarkers / metabolism
  • Cell Proliferation
  • Cells, Cultured
  • Cellular Senescence* / drug effects
  • DNA Breaks, Double-Stranded
  • Doxorubicin / pharmacology
  • Female
  • Hippocampus / drug effects
  • Hippocampus / enzymology*
  • Hippocampus / pathology
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Male
  • Mice, Inbred C57BL
  • Neurons / drug effects
  • Neurons / enzymology*
  • Neurons / pathology
  • Phenotype
  • Repressor Proteins / metabolism
  • Time Factors
  • beta-Galactosidase / metabolism*

Substances

  • Biomarkers
  • Interleukin-6
  • RE1-silencing transcription factor
  • Repressor Proteins
  • interleukin-6, mouse
  • Doxorubicin
  • beta-Galactosidase